Menthol 0.001 MG/MG Topical Ointment [Lysine Plus] — RxCUI 1812685
RxNorm drug concept · Semantic branded drug
RxCUI 1812685
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1812685
Official nameMenthol 0.001 MG/MG Topical Ointment [Lysine Plus]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLysine Plus 0.1 % Topical Ointment
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Menthol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Menthol is found in a lot of over-the-counter topical products — creams, gels, patches, sprays, and powders. Depending on the product, it's used to temporarily ease minor muscle an...
- Start with clean, dry skin — free of lotions or creams — before applying the patch. Peel the backing off and press the sticky side firmly to the sore area. Most menthol patches sho...
- Yes, a mild burning or tingling feeling right after applying a menthol product is common and usually settles down within a few days of regular use. What's not normal is severe burn...
- Is that burning sensation after I apply it normal?
🕸️ Concept Web — How Menthol 0.001 MG/MG Topical Ointment [Lysine Plu... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Menthol 0.001 MG/MG Topical Ointment [Lysine Plus]
RxCUI 1812685 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Menthol
6750IN
-
Menthol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lysine Plus
1812681BN
-
Lysine Plus
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Menthol Topical Ointment
376512SCDF -
Menthol Topical Product
1160376SCDG -
Menthol Topical Ointment [Lysine Plus]
1812683SBDF -
Lysine Plus Topical Product
1812684SBDG -
Topical Ointment
316985DF -
Topical Product
1151122DFG
-
Menthol Topical Ointment
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Menthol 0.001 MG/MG Topical Ointment
1812680SCD -
Menthol 0.001 MG/MG
440882SCDC -
Menthol 0.001 MG/MG [Lysine Plus]
1812682SBDC
-
Menthol 0.001 MG/MG Topical Ointment
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Menthol 0.001 MG/MG Topical Ointment
SCD · 1812680 -
Menthol 0.001 MG/MG
SCDC · 440882 -
Menthol Topical Ointment
SCDF · 376512 -
Menthol Topical Product
SCDG · 1160376
Brand-Name Concepts
-
Menthol 0.001 MG/MG [Lysine Plus]
SBDC · 1812682 -
Menthol Topical Ointment [Lysine Plus]
SBDF · 1812683 -
Lysine Plus Topical Product
SBDG · 1812684 -
Lysine Plus
BN · 1812681
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1812685 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 70084-0320-07 | 1 TUBE in 1 CARTON (70084-320-07) / 7 g in 1 TUBE | Lip Clear Lysine Plus | Quantum, Inc. | 1984-10-01 |
Observed labelers:
Quantum, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.